BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18632875)

  • 21. Spinal meningioma: chronicles of contemporary neurosurgical diagnosis and management.
    Saraceni C; Harrop JS
    Clin Neurol Neurosurg; 2009 Apr; 111(3):221-6. PubMed ID: 19101080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant therapy for unresectable meningiomas: benign and malignant.
    Chen TC; Chamberlain MC
    Neurosurg Focus; 2007; 23(4):1. PubMed ID: 18081514
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of granulosa cell tumour of the ovary.
    Jamieson S; Fuller PJ
    Curr Opin Oncol; 2008 Sep; 20(5):560-4. PubMed ID: 19106661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic cancer metastasis in a meningioma: report of two cases and review of the literature.
    Lanotte M; Benech F; Panciani PP; Cassoni P; Ducati A
    Clin Neurol Neurosurg; 2009 Jan; 111(1):87-93. PubMed ID: 18930586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of meningiomas in South Africa: investigating a correlation between clinical presentation, histopathology and genetic markers.
    Vivier J; Bardien S; Van der Merwe L; Brusnicky J; Zaharie D; Keyser R; Hewlett R; de Jong G; Hartzenberg B
    Br J Neurosurg; 2009 Feb; 23(1):63-70. PubMed ID: 19234911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone therapy for epithelial ovarian cancer.
    Langdon SP; Smyth JF
    Curr Opin Oncol; 2008 Sep; 20(5):548-53. PubMed ID: 19106659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic endonasal resection of anterior cranial base meningiomas.
    Gardner PA; Kassam AB; Thomas A; Snyderman CH; Carrau RL; Mintz AH; Prevedello DM
    Neurosurgery; 2008 Jul; 63(1):36-52; discussion 52-4. PubMed ID: 18728567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid signal in evaluation of intracranial meningiomas.
    Qi ZG; Li YX; Wang Y; Geng DY; Li KC; Shen TZ; Chen XR
    Chin Med J (Engl); 2008 Dec; 121(23):2415-9. PubMed ID: 19102960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing the efficacy of hormonal agents with selected targeted agents.
    Johnston SR
    Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S28-36. PubMed ID: 19561004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative Therapeutic Strategies in the Treatment of Meningioma.
    Caruso G; Elbabaa SK; Gonzalez-Lopez P; Barresi V; Passalacqua M; Caffo M
    Anticancer Res; 2015 Dec; 35(12):6391-400. PubMed ID: 26637848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aquaporin-4 expression is increased in edematous meningiomas.
    Ng WH; Hy JW; Tan WL; Liew D; Lim T; Ang BT; Ng I
    J Clin Neurosci; 2009 Mar; 16(3):441-3. PubMed ID: 19153045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of endometrial cancer.
    Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
    Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.